For the quarter ended March 2025, AMN Healthcare Services (AMN) reported revenue of $689.53 million, down 16% over the same period last year. EPS came in at $0.45, compared to $0.97 in the year-ago quarter. The reported revenue represents a surprise of +2.72% over the Zacks Consensus Estimate of $671.3 million. With the consensus EPS estimate being $0.19, the EPS surprise was +136.84%. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health. Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance. Here is how AMN Healthcare performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Physician and leadership solutions - Days Filled: 51.34 million versus the two-analyst average estimate of 51.95 million. Physician and leadership solutions - Revenue per day filled: $2.74 million versus $2.63 million estimated by two analysts on average. Revenue- Physician and leadership solutions: $174.07 million versus the four-analyst average estimate of $171.10 million. The reported number represents a year-over-year change of -7.8%. Revenue- Nurse and allied solutions: $413.26 million versus the four-analyst average estimate of $397.20 million. The reported number represents a year-over-year change of -20.4%. Revenue- Technology and workforce solutions: $102.21 million versus $103 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -9.4% change. Segment operating income- Nurse and allied solutions: $32.24 million versus $30.79 million estimated by two analysts on average. Segment operating income- Technology and workforce solutions: $35.25 million compared to the $37.97 million average estimate based on two analysts. Segment operating income- Physician and leadership solutions: $14.46 million versus $17.29 million estimated by two analysts on average. View all Key Company Metrics for AMN Healthcare here>>> Shares of AMN Healthcare have returned -5.3% over the past month versus the Zacks S&P 500 composite's +11.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Story Continues AMN Healthcare Services Inc (AMN):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
AMN Healthcare (AMN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...